NCT01730872View on ClinicalTrials.gov

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Chronic Allergic Conjunctivitis
Interventions
DRUG

Prednisolone Sodium Phosphate Ophthalmic Solution 1%

One drop in each eye, four times/day for 4 days.

DRUG

Tears Naturale II Ophthalmic Solution

one drop in each eye, four times/ day (QID) for 4 days

Trial Locations (1)

01810

Andover Eye Associates, Andover

All Listed Sponsors
lead

ORA, Inc.

INDUSTRY

NCT01730872 - Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model | Biotech Hunter | Biotech Hunter